Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The Oxycodone Drugs Industry By 2029?

The market for oxycodone drugs has seen robust growth in the past years. The market size is projected to increase from $5.62 billion in 2024 to $5.98 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.4%. This growth during the historic period is largely due to an aggressive marketing campaign for Oxycontin, which was promoted for chronic non-malignant pain and cancer care. The increase in prescriptions of Oxycontin for non-cancer-related pain significantly boosted the demand for these drugs. Moreover, post the second world war, the market saw an influx of synthetic opiates like oxycodone.

The market size of oxycodone drugs is projected to witness robust growth in the forthcoming years, escalating to $7.66 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 6.4%. The anticipated growth during the forecast period can be credited to the growing cases of chronic pain, an uptick in surgical procedures, continuous advancements in the products pipeline which is poised to trigger growth, improvements in drug delivery mechanisms, and an increasing aging global demographic suffering from higher rates of chronic pain. In the forecast period, foremost trends include heightening demand for abuse-deterrent formulations (ADFS), the creation of innovative delivery systems, the escalating preference for combination therapies, and technological strides in manufacturing.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp

Which Industry Forces Are Driving The Oxycodone Drugs Market Forward?

The oxycodone drug market is predicted to escalate due to the high prevalence of orthopedic disorders. These disorders encompass various musculoskeletal conditions affecting bones, joints, ligaments, tendons, and muscles, causing pain, restricted movement, and functional impairments. Factors like aging population, inactive lifestyles, obesity, sports-related injuries, and work-related risks contribute to the growing incidents of orthopedic disorders. Oxycodone drugs, used for mitigating acute and chronic pain caused by fractures, joint injuries, or postoperative discomfort, offer efficient pain relief by targeting the pain receptors in the central nervous system. For example, the Institute for Health Metrics and Evaluation, a research institute based in the US, predicted in October 2023 that cases of musculoskeletal disorders (orthopedic disorders) will potentially increase by 115% (ranging from 107–124%) between 2020 and 2050, with an estimated 1,060 million prevalent cases projected by 2050. Consequently, the substantial prevalence of orthopedic disorders is fueling the oxycodone drug market’s expansion.

What Are The Key Segment Trends Observed In The Oxycodone Drugs Market?

The oxycodone drugs market covered in this report is segmented –

1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone

2) By Dosage Form: Tablets, Capsules, Injections

3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution

2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations

Which Disruptive Trends Are Driving Change Across The Oxycodone Drugs Market?

Leading firms in the oxycodone drug market are concentrating on producing innovative medications, including oxycodone immediate-release (IR) tablets, in an attempt to curtail drug misuse through injection and intranasal methods. Oxycodone immediate-release (IR) tablets are a version of the opioid analgesic oxycodone, created to offer quick pain alleviation. For example, Protega Pharmaceuticals LLC, a US-based drug company, introduced RoxyBond (oxycodone) immediate-release (IR) tablets within the United States in July 2022. The U.S. Food and Drug Administration (FDA) has permitted RoxyBond for the management of severe pain requiring an opioid analgesic when other alternatives are inadequate. It incorporates sophisticated technology to avert potential abuse and misuse, making it challenging to manipulate either physically or chemically.

Who Are The Major Stakeholders Operating In The Oxycodone Drugs Market?

Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

What Regional Factors Are Accelerating Growth In The Oxycodone Drugs Market?

North America was the largest region in the oxycodone drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15886&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model